SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-12-000025
Filing Date
2012-05-04
Accepted
2012-05-04 11:29:01
Documents
19
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 999106
2 exhibit10-4.htm EX-10.4 596316
3 exhibit10_4.jpg GRAPHIC 228486
4 g61.jpg GRAPHIC 37647
5 h3.jpg GRAPHIC 17424
6 h5.jpg GRAPHIC 30814
7 h7.jpg GRAPHIC 36160
8 exhibit10-5.htm EX-10.5 62792
9 exhibit10-6.htm EX-10.6 12999
10 j.jpg GRAPHIC 54362
11 exhibit31-1.htm EX-31.1 8970
12 exhibit31-2.htm EX-31.2 9262
13 exhibit32-1.htm EX-32.1 4842
14 exhibit32-2.htm EX-32.2 4827
  Complete submission text file 0001367644-12-000025.txt   4294159

Data Files

Seq Description Document Type Size
15 ebs-20120331.xml EX-101.INS 305739
16 ebs-20120331.xsd EX-101.SCH 21490
17 ebs-20120331_cal.xml EX-101.CAL 60044
18 ebs-20120331_lab.xml EX-101.LAB 257496
19 ebs-20120331_pre.xml EX-101.PRE 122481
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 12812655
SIC: 2834 Pharmaceutical Preparations